Edwards Lifesciences EBITDA Margin 2010-2024 | EW

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Edwards Lifesciences (EW) over the last 10 years. The current EBITDA margin for Edwards Lifesciences as of March 31, 2024 is .
Edwards Lifesciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $6.14B $1.68B 27.36%
2023-12-31 $6.01B $1.68B 27.96%
2023-09-30 $5.82B $1.73B 29.64%
2023-06-30 $5.66B $1.71B 30.19%
2023-03-31 $5.50B $1.84B 33.43%
2022-12-31 $5.38B $1.89B 35.08%
2022-09-30 $5.36B $1.81B 33.78%
2022-06-30 $5.36B $1.80B 33.58%
2022-03-31 $5.36B $1.88B 35.13%
2021-12-31 $5.23B $1.83B 34.87%
2021-09-30 $5.10B $1.80B 35.37%
2021-06-30 $4.93B $1.76B 35.75%
2021-03-31 $4.48B $1.04B 23.20%
2020-12-31 $4.39B $1.01B 22.91%
2020-09-30 $4.37B $0.96B 21.88%
2020-06-30 $4.32B $0.89B 20.59%
2020-03-31 $4.48B $1.32B 29.53%
2019-12-31 $4.35B $1.24B 28.43%
2019-09-30 $4.15B $0.92B 22.06%
2019-06-30 $3.97B $0.87B 21.87%
2019-03-31 $3.82B $0.85B 22.21%
2018-12-31 $3.72B $0.83B 22.18%
2018-09-30 $3.64B $1.14B 31.28%
2018-06-30 $3.55B $1.12B 31.46%
2018-03-31 $3.45B $1.11B 32.31%
2017-12-31 $3.44B $1.17B 34.10%
2017-09-30 $3.32B $1.04B 31.27%
2017-06-30 $3.23B $1.00B 31.02%
2017-03-31 $3.15B $0.97B 30.73%
2016-12-31 $2.96B $0.86B 28.89%
2016-09-30 $2.87B $0.85B 29.80%
2016-06-30 $2.74B $0.81B 29.68%
2016-03-31 $2.60B $0.75B 28.64%
2015-12-31 $2.49B $0.71B 28.39%
2015-09-30 $2.44B $0.69B 28.19%
2015-06-30 $2.43B $0.66B 27.22%
2015-03-31 $2.39B $0.63B 26.49%
2014-12-31 $2.32B $0.56B 24.20%
2014-09-30 $2.24B $0.54B 24.02%
2014-06-30 $2.13B $0.51B 24.10%
2014-03-31 $2.07B $0.52B 25.06%
2013-12-31 $2.05B $0.54B 26.15%
2013-09-30 $2.02B $0.55B 26.98%
2013-06-30 $1.97B $0.53B 26.93%
2013-03-31 $1.94B $0.50B 25.81%
2012-12-31 $1.90B $0.47B 24.96%
2012-09-30 $1.82B $0.42B 23.09%
2012-06-30 $1.78B $0.39B 21.58%
2012-03-31 $1.73B $0.37B 21.06%
2011-12-31 $1.68B $0.36B 21.32%
2011-09-30 $1.64B $0.35B 21.51%
2011-06-30 $1.58B $0.36B 22.83%
2011-03-31 $1.51B $0.36B 23.63%
2010-12-31 $1.45B $0.34B 23.57%
2010-09-30 $1.40B $0.32B 23.11%
2010-06-30 $1.38B $0.32B 22.84%
2010-03-31 $1.35B $0.31B 22.59%
2009-12-31 $1.32B $0.30B 22.45%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $54.101B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.743B 27.48
Intuitive Surgical (ISRG) United States $141.891B 85.48
DexCom (DXCM) United States $51.973B 78.73
IDEXX Laboratories (IDXX) United States $43.777B 51.31
Alcon (ALC) Switzerland $43.442B 31.13
IQVIA Holdings (IQV) United States $41.922B 24.32
STERIS (STE) Ireland $22.999B 26.88
Waters (WAT) United States $21.000B 30.86
SONOVA HOLDING (SONVY) Switzerland $18.908B 0.00
Hologic (HOLX) United States $17.468B 19.54
Fresenius Medical Care AG KGaA (FMS) Germany $12.869B 15.02
ShockWave Medical (SWAV) United States $12.384B 77.07
Sysmex ADR (SSMXY) Japan $11.134B 34.91
Teleflex (TFX) United States $10.108B 15.73
Globus Medical (GMED) United States $8.970B 26.29
Penumbra (PEN) United States $7.809B 88.74
Masimo (MASI) United States $6.723B 38.73
Glaukos (GKOS) United States $5.504B 0.00
TransMedics (TMDX) United States $4.566B 433.19
Integer Holdings (ITGR) United States $4.029B 24.34
PROCEPT BioRobotics (PRCT) United States $3.533B 0.00
LivaNova (LIVN) United Kingdom $3.318B 19.70
Tandem Diabetes Care (TNDM) United States $3.051B 0.00
Elekta AB (EKTAY) Sweden $2.973B 20.40
Inari Medical (NARI) United States $2.682B 0.00
Nihon Kohden (NHNKY) Japan $2.474B 20.92
RxSight (RXST) United States $2.317B 0.00
Integra LifeSciences Holdings (IART) United States $2.126B 9.27
Veracyte (VCYT) United States $1.705B 0.00
Alphatec Holdings (ATEC) United States $1.543B 0.00
Artivion (AORT) United States $0.993B 95.24
AVANOS MEDICAL, INC (AVNS) United States $0.933B 18.14
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.897B 0.00
OrthoPediatrics (KIDS) United States $0.775B 0.00
Mesa Laboratories (MLAB) United States $0.656B 22.26
Paragon 28 (FNA) United States $0.621B 0.00
SiBone (SIBN) United States $0.593B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.567B 0.00
IRadimed (IRMD) United States $0.555B 31.07
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Pulse Biosciences (PLSE) United States $0.474B 0.00
Nevro (NVRO) United States $0.386B 0.00
Tactile Systems Technology (TCMD) United States $0.324B 11.10
Treace Medical Concepts (TMCI) United States $0.306B 0.00
Sight Sciences (SGHT) United States $0.282B 0.00
AxoGen (AXGN) United States $0.271B 0.00
908 Devices (MASS) United States $0.236B 0.00
AngioDynamics (ANGO) United States $0.233B 0.00
EDAP TMS S.A (EDAP) France $0.231B 0.00
NeuroPace (NPCE) United States $0.230B 0.00
Delcath Systems (DCTH) United States $0.223B 0.00
Inogen (INGN) United States $0.207B 0.00
Atossa Genetics (ATOS) United States $0.201B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.168B 0.00
Semler Scientific (SMLR) United States $0.166B 8.42
Accuray (ARAY) United States $0.159B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.103B 21.59
KORU Medical Systems (KRMD) United States $0.101B 0.00
Yubo Biotech (YBGJ) China $0.091B 0.00
Neuronetics (STIM) United States $0.076B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Envoy Medical (COCH) United States $0.064B 0.00
Monogram Orthopaedics (MGRM) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.056B 0.00
SEP Acquisition (SEPA) United States $0.054B 0.00
DarioHealth (DRIO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.046B 0.00
Autonomix Medical (AMIX) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
T2 Biosystems (TTOO) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Aspira Women's Health (AWH) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00